Rockland Trust Co. Purchases 63,538 Shares of Elevance Health, Inc. $ELV

Key Points

• Rockland Trust Co. increased its stake in Elevance Health by 8,251.7%, buying 63,538 shares to hold 64,308 shares worth about $22.54 million at the end of the quarter.
• Q4 results: Elevance reported $3.33 EPS versus $3.10 expected and revenue of $49.31 billion (up 9.6% YoY), set FY‑2026 guidance at 25.50 EPS, and carries a consensus analyst rating of "Moderate Buy" with a $387.40 target.
• Dividend and ownership: Elevance raised its quarterly dividend to $1.72 ($6.88 annualized, ~2.3% yield) and roughly 89.2% of the stock is held by institutional investors.

Rockland Trust Co. boosted its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 8,251.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 64,308 shares of the company's stock after purchasing an additional 63,538 shares during the quarter. Rockland Trust Co.'s holdings in Elevance Health were worth $22,543,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Physician Wealth Advisors Inc. raised its holdings in Elevance Health by 331.6% in the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock worth $26,000 after buying an additional 63 shares during the last quarter. Activest Wealth Management grew its holdings in shares of Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company's stock valued at $27,000 after buying an additional 34 shares during the last quarter. Rossby Financial LCC grew its holdings in shares of Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company's stock valued at $28,000 after buying an additional 44 shares during the last quarter. Motco increased its position in shares of Elevance Health by 334.8% during the third quarter. Motco now owns 100 shares of the company's stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. Finally, True Wealth Design LLC increased its position in shares of Elevance Health by 431.8% during the third quarter. True Wealth Design LLC now owns 117 shares of the company's stock valued at $38,000 after acquiring an additional 95 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors.

Elevance Health Stock Up 2.9%

Shares of Elevance Health stock opened at $293.10 on Wednesday. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.70. The company's 50 day moving average is $318.92 and its 200 day moving average is $332.55. The company has a market cap of $64.38 billion, a price-to-earnings ratio of 11.67, a price-to-earnings-growth ratio of 1.56 and a beta of 0.51.

Elevance Health (NYSE:ELV - Get Free Report) last posted its earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping analysts' consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion during the quarter, compared to the consensus estimate of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The firm's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.84 EPS. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Research analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 25th. Investors of record on Tuesday, March 10th were issued a $1.72 dividend. The ex-dividend date of this dividend was Tuesday, March 10th. This is an increase from Elevance Health's previous quarterly dividend of $1.71. This represents a $6.88 annualized dividend and a dividend yield of 2.3%. Elevance Health's dividend payout ratio is presently 27.39%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ELV shares. Guggenheim lowered their price objective on Elevance Health from $414.00 to $396.00 and set a "buy" rating on the stock in a research report on Thursday, January 29th. Leerink Partners lifted their target price on Elevance Health from $350.00 to $357.00 and gave the stock a "market perform" rating in a report on Thursday, January 29th. Wells Fargo & Company decreased their price target on Elevance Health from $424.00 to $391.00 and set an "overweight" rating for the company in a research note on Friday, January 30th. Mizuho lowered their price target on Elevance Health from $413.00 to $350.00 and set an "outperform" rating on the stock in a report on Wednesday, March 11th. Finally, Truist Financial dropped their price objective on Elevance Health from $400.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, February 2nd. Twelve equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $387.40.

Elevance Health Company Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.